Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Gilbert

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Journal of Diabetes and Its Complications|February 4, 2017
Finerenone in diabetic kidney disease - So far, so goodRichard E Gilbert
Current Atherosclerosis Reports|March 14, 2014
The endothelium in diabetic nephropathyRichard E Gilbert
Kidney International|April 1, 2014
The perils of clinical trialsRichard E Gilbert
Kidney International|November 1, 2014
The author repliesRichard E Gilbert
Kidney International|November 22, 2013
Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?Richard E Gilbert
The Lancet. Diabetes & Endocrinology|September 10, 2019
Diabetic kidney disease 2.0: the treatment paradigm shiftsRichard E Gilbert
Journal of Diabetes|December 3, 2014
Heart failure in SAVOR-TIMI 53: The hindsight of diabetic retinopathyRichard E Gilbert
The Lancet. Diabetes & Endocrinology|September 25, 2016
SGLT2 inhibitors: β blockers for the kidney?Richard E Gilbert
Clinical Journal of the American Society of Nephrology : CJASN|October 12, 2007
Rosiglitazone: opening Pandora's black box?Richard E Gilbert
Circulation Journal : Official Journal of the Japanese Circulation Society|March 19, 2013
Endothelial loss and repair in the vascular complications of diabetes: pathogenetic mechanisms and therapeutic implicationsRichard E Gilbert
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Journal of Diabetes and Its Complications|February 4, 2017
Finerenone in diabetic kidney disease - So far, so goodRichard E Gilbert
Current Atherosclerosis Reports|March 14, 2014
The endothelium in diabetic nephropathyRichard E Gilbert
Kidney International|April 1, 2014
The perils of clinical trialsRichard E Gilbert
Kidney International|November 1, 2014
The author repliesRichard E Gilbert
Kidney International|November 22, 2013
Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?Richard E Gilbert
The Lancet. Diabetes & Endocrinology|September 10, 2019
Diabetic kidney disease 2.0: the treatment paradigm shiftsRichard E Gilbert
Journal of Diabetes|December 3, 2014
Heart failure in SAVOR-TIMI 53: The hindsight of diabetic retinopathyRichard E Gilbert
The Lancet. Diabetes & Endocrinology|September 25, 2016
SGLT2 inhibitors: β blockers for the kidney?Richard E Gilbert
Clinical Journal of the American Society of Nephrology : CJASN|October 12, 2007
Rosiglitazone: opening Pandora's black box?Richard E Gilbert
Circulation Journal : Official Journal of the Japanese Circulation Society|March 19, 2013
Endothelial loss and repair in the vascular complications of diabetes: pathogenetic mechanisms and therapeutic implicationsRichard E Gilbert
Pageof 18